Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Hospital
1120
mi
from 02139
Coon Rapids, MN
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
UC Irvine Health Cancer Center-Newport
2584
mi
from 02139
Costa Mesa, CA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Greater Regional Medical Center
1199
mi
from 02139
Creston, IA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
UT Southwestern/Simmons Cancer Center-Dallas
1547
mi
from 02139
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Parkland Memorial Hospital
1547
mi
from 02139
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Sutter Davis Hospital
2635
mi
from 02139
Davis, CA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Dayton Physicians LLC-Samaritan North
705
mi
from 02139
Dayton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
National Jewish Health-Main Campus
1761
mi
from 02139
Denver, CO
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Rose Medical Center
1759
mi
from 02139
Denver, CO
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Iowa Lutheran Hospital
1154
mi
from 02139
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Essentia Health Saint Mary's Medical Center
1073
mi
from 02139
Duluth, MN
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Fairview Southdale Hospital
1121
mi
from 02139
Edina, MN
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Crossroads Cancer Center
938
mi
from 02139
Effingham, IL
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Regional Cancer Partnership
2472
mi
from 02139
Everett, WA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Genesee Cancer & Blood Disease Treatment Center, PC
640
mi
from 02139
Flint, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
UT Southwestern/Simmons Cancer Center-Fort Worth
1574
mi
from 02139
Fort Worth, TX
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Mountain Blue Cancer Care Center
1774
mi
from 02139
Golden, CO
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Wayne Hospital
719
mi
from 02139
Greenville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Smilow Cancer Hospital Care Center at Saint Francis
91
mi
from 02139
Hartford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Geisinger Medical Center-Cancer Center Hazleton
269
mi
from 02139
Hazleton, PA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Park Ridge Health
778
mi
from 02139
Hendersonville, NC
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Pulmonary Medicine Center of Chattanooga-Hixson
908
mi
from 02139
Hixson, TN
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
The Cancer Center of Hawaii-Liliha
5077
mi
from 02139
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Allegiance Health
678
mi
from 02139
Jackson, MI
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Valley Eye Physicians & Surgeons
28
mi
from 02139
Ayer, MA
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Elman Retina Group, PA
351
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retinal Diagnostic Center
2680
mi
from 02139
Campbell, CA
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Charlotte Eye Ear Nose and Throat Assoc, PA
724
mi
from 02139
Charlotte, NC
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Southeastern Retina Associates
915
mi
from 02139
Chattanooga, TN
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Vitreo-Retinal Associates
736
mi
from 02139
Grand Rapids, MI
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Dean A. McGee Eye Institute
1489
mi
from 02139
Oklahoma City, OK
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Retina Institute
1033
mi
from 02139
Saint Louis, MO
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Study Site
1760
mi
from 02139
Centennial, CO
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Study Site
847
mi
from 02139
Chicago, IL
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Study Site
1182
mi
from 02139
Tampa, FL
Click here to add this to my saved trials
Influenza Vaccination Clinical Trial
Study of Immune Responses to Influenza Vaccination
Status: Enrolling, Phase IV
Updated: 12/31/1969
Univ of Pennsylvania
270
mi
from 02139
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Early Feasibility Study of the AccuCinch® Ventricular Repair System - The CorCinch-FMR Study
Status: Enrolling
Updated: 12/31/1969
Hackensack University Medical Center
183
mi
from 02139
Hackensack, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Early Feasibility Study of the AccuCinch® Ventricular Repair System - The CorCinch-FMR Study
Status: Enrolling
Updated: 12/31/1969
University of Louisville
821
mi
from 02139
Louisville, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Early Feasibility Study of the AccuCinch® Ventricular Repair System - The CorCinch-FMR Study
Status: Enrolling
Updated: 12/31/1969
University of Washington Medicine
2483
mi
from 02139
Seattle, WA
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Delineating Swallowing Impairment and Decline in ALS
Status: Enrolling, Phase
Updated: 12/31/1969
University of Florida
1078
mi
from 02139
Gainesville, FL
Click here to add this to my saved trials
Other Clinical Trial
Preventing Adverse Incisional Outcomes at Cesarean Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Barnes Jewish Hospital
1036
mi
from 02139
Saint Louis, MO
Click here to add this to my saved trials
Stem Cell Transplant Complications Clinical Trial
A Double-blind Randomized Placebo Controlled Clinical Trial Evaluating Effect of Chlorhexidine Gluconate 2% Cloth vs Placebo Cloth Baths on the Incidence of Central Line-Associated Blood Stream Infections in Outpatient Hematopoietic Stem Cell Transplant Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Chicago
845
mi
from 02139
Chicago, IL
Click here to add this to my saved trials
Smoking Cessation Clinical Trial
Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants
Status: Enrolling, Phase IV
Updated: 12/31/1969
New York University School of Medicine
185
mi
from 02139
New York, NY
Click here to add this to my saved trials
Endocrinology Clinical Trial
Low Carbohydrate/High Protein Diet to Improve Metabolic Health
Status: Enrolling
Updated: 12/31/1969
UAB
1048
mi
from 02139
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada
2377
mi
from 02139
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Virginia Mason Medical Center
2483
mi
from 02139
Seattle, WA
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site
816
mi
from 02139
Louisville, KY
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site 1345
1260
mi
from 02139
Miami, FL
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site 10664
1249
mi
from 02139
North Miami, FL
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site
2530
mi
from 02139
Portland, OR
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site
2576
mi
from 02139
San Diego, CA
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site 10124
2256
mi
from 02139
Spokane, WA
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site 10103
1610
mi
from 02139
Waco, TX
Click here to add this to my saved trials
Infantile Spasm Clinical Trial
A Novel Approach to Infantile Spasms
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Colorado Anschutz Medical Campus
1755
mi
from 02139
Aurora, CO
Click here to add this to my saved trials
Neurology, Orthopedics / Podiatry, Other Clinical Trial
Effects of Mobility Dose on Discharge Disposition in Critically Ill Stroke Patients
Status: Enrolling, Phase
Updated: 12/31/1969
Beth Israel Deconess Medical Center
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Degenerative Disc Disease Clinical Trial
Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Southern California
2586
mi
from 02139
Los Angeles, CA
Click here to add this to my saved trials
Degenerative Disc Disease Clinical Trial
Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Physicians Research Options
2094
mi
from 02139
Draper, UT
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
1
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Lahey Clinic
10
mi
from 02139
Burlington, MA
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Morton Plant Hospital
1192
mi
from 02139
Clearwater, FL
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Genesis Medical Center
999
mi
from 02139
Davenport, IA
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
McLaren Flint
638
mi
from 02139
Flint, MI
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Pinnacle Health Cardiovascular Institute
332
mi
from 02139
Harrisburg, PA
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Heart Center Research, Llc
986
mi
from 02139
Huntsville, AL
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Turkey Creek Medical Center
815
mi
from 02139
Knoxville, TN
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
MidMichigan Medical Center - Midland
669
mi
from 02139
Midland, MI
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Abbott Northwestern Hospital
1120
mi
from 02139
Minneapolis, MN
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
New York Presbyterian Hospital (Cornell)
184
mi
from 02139
New York, NY
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
University of California, Davis Medical Center
2622
mi
from 02139
Sacramento, CA
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Scottsdale Healthcare
2275
mi
from 02139
Scottsdale, AZ
Click here to add this to my saved trials
Coronary Artery Lesions Clinical Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Status: Enrolling
Updated: 12/31/1969
Tallahassee Memorial Hospital
1090
mi
from 02139
Tallahassee, FL
Click here to add this to my saved trials
Advanced Head and Neck Squamous Cell Carcinoma Clinical Trial
A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Vanderbilt University Medical Center
940
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
Advanced Head and Neck Squamous Cell Carcinoma Clinical Trial
A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Emory University/Winship Cancer Institute
929
mi
from 02139
Atlanta, GA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
U3-1402 in Metastatic or Unresectable EGFR-mutant Non-Small Cell Lung Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Winship Cancer Institute at Emory University
929
mi
from 02139
Atlanta, GA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
U3-1402 in Metastatic or Unresectable EGFR-mutant Non-Small Cell Lung Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Dana-Farber Cancer Institute
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
U3-1402 in Metastatic or Unresectable EGFR-mutant Non-Small Cell Lung Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
184
mi
from 02139
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
PF-06804103 Dose Escalation in HER2 Positive Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Santa Monica/UCLA Medical Center and Orthopaedic Hospital
2600
mi
from 02139
Santa Monica, CA
Click here to add this to my saved trials
Oncology Clinical Trial
PF-06804103 Dose Escalation in HER2 Positive Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
UCLA Hematology-Oncology Santa Monica
2602
mi
from 02139
Santa Monica, CA
Click here to add this to my saved trials
Neurology Clinical Trial
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
Status: Enrolling, Phase IV
Updated: 12/31/1969
U.T. Southwestern Medical Center
1546
mi
from 02139
Dallas, TX
Click here to add this to my saved trials
Neurology Clinical Trial
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
Status: Enrolling, Phase IV
Updated: 12/31/1969
Minneapolis Clinic of Neurology
1122
mi
from 02139
Golden Valley, MN
Click here to add this to my saved trials
Neurology Clinical Trial
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
Status: Enrolling, Phase IV
Updated: 12/31/1969
Children's Hospital of San Antonio
1764
mi
from 02139
San Antonio, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
Baylor College of Medicine
1601
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
Nemours Children's Clinic - Orlando
1115
mi
from 02139
Orlando, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
Center for Children's Digestive Health
855
mi
from 02139
Park Ridge, IL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
The Mayo Clinic
1079
mi
from 02139
Rochester, MN
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling, Phase II
Updated: 12/31/1969
Willis-Knighton Physician Network
1410
mi
from 02139
Shreveport, LA
Click here to add this to my saved trials
Dengue Clinical Trial
Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Johnson County Clin-Trials
1258
mi
from 02139
Lenexa, KS
Click here to add this to my saved trials
Eating Disorder Clinical Trial
Brain Function in Adolescent Eating Disorders and Healthy Peers
Status: Enrolling
Updated: 11/19/2017
University of California, San Diego
2550
mi
from 02139
San Diego, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Roswell Park Cancer Institute
396
mi
from 02139
Buffalo, NY
Click here to add this to my saved trials
Severe Osteoarthritis of the Knee Clinical Trial
An Open Label Extension Study to Assess the Safety of Long-Term Treatment With Ampion for Severe OA of the Knee
Status: Enrolling, Phase III
Updated: 12/19/2017
Heartland Research Associates, LLC
1414
mi
from 02139
Wichita, KS
Click here to add this to my saved trials
Immunologic Deficiency Syndromes Clinical Trial
Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Status: Enrolling, Phase III
Updated: 11/21/2017
Allergy Partners of North Texas Research
1547
mi
from 02139
Dallas, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Michigan
643
mi
from 02139
Ann Arbor, MI
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
Accurate Clinical Research
1601
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
Lakes Research
1251
mi
from 02139
Miami Lakes, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
Virginia Clinical Research, Inc.
469
mi
from 02139
Norfolk, VA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase II
Updated: 12/31/1969
PMG Research of Wilmington
672
mi
from 02139
Wilmington, NC
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Roswell Park Cancer Institute
396
mi
from 02139
Buffalo, NY
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Michigan
643
mi
from 02139
Ann Arbor, MI
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Johns Hopkins Hospital
356
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
University Hospitals of Cleveland Medical Center
547
mi
from 02139
Cleveland, OH
Click here to add this to my saved trials